[Results after treatment with sildenafil citrate in 100 patients with erectile dysfunction].
OBJECTIVE
In order to know the efficiency, tolerance and acceptance of Sildenafil Citrate in our area as a new treatment for Eréctil Dysfunction (E.D.).


METHODS
We include 100 patients with E.D. who were assisted in our medical office from November 1998 to February 2000 to evaluate them according to several predeterminated variables.


RESULTS
The positive response index (E.D. improvement) was 69.9%. We only found side effects in 11.8% (headache 5.4%, flushing 4.3%, diarrhea/blurred vision 2.2%). The most widely used dose was 50 mgrs (65.6%). Only 50.5% of the patients had enough information about Sildenafil. The highest positive response index corresponded to the mild E.D. (76.1%). Also the best results were achieved with the mixed and psychological etiology (74.1%). The Sildenafil treatment was rejected (fear or its price) by the 46.2% of the patients.


CONCLUSIONS
The Sildenafil Citrate is an effective treatment for the E.D. It hardly has any side effects. The 50 mgrs dose got the best results. Almost half of the patients complained about an insufficient information on this pharmaceutical. Sildenafil got a good response even when there were risk associated factors of E.D.
Varela Salgado
M
M
Servicio de Urología, Hospital Montecelo, Pontevedra.
Cadarso Suárez
C
C
García Riestra
V
V
Meirás Barreiro
J C
JC
Pazos Riveiro
J A
JA
Llovo Taboada
F
F
D000328:Adult; D000368:Aged; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use*; D011446:Prospective Studies; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones
D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate
Resultados tras el tratamiento con Citrato de Sildenafilo en 100 pacientes con disfunción eréctil.